The FDA's removal of REMS for CAR T-cell therapies enhances access for community oncology, paving the way for innovative ...

Refat Rasul Srejon, MPH, says reducing opioid-related emergency department (ED) visits among young adults requires strategies like medication-assisted treatment and targeted outreach.

This multicenter, prospective observational study is published in Frontiers in Clinical Diabetes and Healthcare. “Pre-treatment assessment of eating behavior patterns may help predict who will benefit ...

Researchers have found bariatric surgery to be more cost-effective for treating patients with obesity compared with glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to new study ...

Laxmi Patel discusses proposed Medicaid reforms in HR 1, including work rules, coverage limits, and state-level risks for ...

New findings reveal sotatercept's significant benefits for right ventricular function and tricuspid regurgitation in ...

An expert discusses the 2025 NCCN guideline updates for ROS1-positive non-small cell lung cancer, highlighting the inclusion ...

Lower HCRU and costs may be reflective of improved patient care.

The adoption of technologies like telehealth and health information exchange increased over time, but hospitals in the most disadvantaged areas were behind.

Increased use of neoadjuvant chemotherapy (NACT) with interval debulking surgery has changed surgical practice patterns, improving complete resection rates and reducing postoperative complications.

Susan Monarez, PhD, warns of absent evidence, political pressure, and risks to public health after being fired last month by HHS Secretary Robert F. Kennedy Jr.

Shaji Kumar, MD, Mayo Clinic, discusses the July approval of linvoseltamab, a new bispecific antibody for relapsed myeloma, and how it expands treatment options for patients. He also emphasizes the ...